Although DKK1 is a well-characterized inhibitor of the Wnt/β-catenin pathway, some studies have reported that DKK1 and β-catenin are positively correlated, suggesting that the Wnt/β-catenin pathway is activated by DKK1 in HCC cells [24, 25]. Here, DKK1 is linked to hepatocellular carcinoma.